NO177774C - Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel - Google Patents

Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel

Info

Publication number
NO177774C
NO177774C NO880272A NO880272A NO177774C NO 177774 C NO177774 C NO 177774C NO 880272 A NO880272 A NO 880272A NO 880272 A NO880272 A NO 880272A NO 177774 C NO177774 C NO 177774C
Authority
NO
Norway
Prior art keywords
active ingredient
administration
preparation
triglyceride
composition suitable
Prior art date
Application number
NO880272A
Other languages
English (en)
Norwegian (no)
Other versions
NO880272D0 (no
NO880272L (no
NO177774B (no
Inventor
Eric Anton Forssen
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21725588&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO177774(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vestar Inc filed Critical Vestar Inc
Publication of NO880272D0 publication Critical patent/NO880272D0/no
Publication of NO880272L publication Critical patent/NO880272L/no
Publication of NO177774B publication Critical patent/NO177774B/no
Publication of NO177774C publication Critical patent/NO177774C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
NO880272A 1987-01-27 1988-01-22 Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel NO177774C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US733887A 1987-01-27 1987-01-27

Publications (4)

Publication Number Publication Date
NO880272D0 NO880272D0 (no) 1988-01-22
NO880272L NO880272L (no) 1988-07-27
NO177774B NO177774B (no) 1995-08-14
NO177774C true NO177774C (no) 1995-11-22

Family

ID=21725588

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880272A NO177774C (no) 1987-01-27 1988-01-22 Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel

Country Status (13)

Country Link
US (1) US4963363A (fr)
EP (1) EP0280394B1 (fr)
JP (1) JP2677576B2 (fr)
KR (1) KR960009181B1 (fr)
AT (1) ATE115403T1 (fr)
AU (1) AU604288B2 (fr)
CA (1) CA1314213C (fr)
DE (1) DE3852409T2 (fr)
DK (1) DK32388A (fr)
ES (1) ES2068197T3 (fr)
GR (1) GR3015290T3 (fr)
IE (1) IE65987B1 (fr)
NO (1) NO177774C (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03128321A (ja) * 1989-06-12 1991-05-31 Res Inst For Prod Dev 人工酸素運搬体
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5221535A (en) * 1989-11-13 1993-06-22 Nova Pharmaceutical Corporation Sustained release formulations of insect repellent
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas
US5885486A (en) * 1993-03-05 1999-03-23 Pharmaciaand Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5714163A (en) * 1994-06-27 1998-02-03 Nexstar Pharmaceuticals, Inc. Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
US6120800A (en) * 1997-09-25 2000-09-19 Nexstar Pharmaceuticals, Inc. Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
TWI241915B (en) 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
WO2003032903A2 (fr) * 2001-10-12 2003-04-24 New York University Composes de triazine trisubstitues a activite anti-tubuline, procedes d'elaboration et d'utilisation correspondants
US7592451B2 (en) * 2005-06-23 2009-09-22 New York University Treatment for diabetes and obesity as well as method of screening compounds useful for such treatments
JP6661319B2 (ja) * 2015-09-28 2020-03-11 小林製薬株式会社 リポソーム

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
CA1119955A (fr) * 1978-04-14 1982-03-16 Little (Arthur D.), Inc. Vehicule pour la dispensation de produits xenobiotiques, methode de formation et d'utilisation desdits vehicules
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
US4534899A (en) * 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
FR2534487B1 (fr) * 1982-10-15 1988-06-10 Dior Christian Parfums Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk 1−〔2−(2,4−ジクロロフエニル)−3−メチル−1−ペンテニル〕−1h−イミダゾ−ルを含有する水中油型脂肪乳剤

Also Published As

Publication number Publication date
DK32388D0 (da) 1988-01-25
KR960009181B1 (ko) 1996-07-16
AU1073688A (en) 1988-07-28
DE3852409D1 (de) 1995-01-26
NO880272D0 (no) 1988-01-22
GR3015290T3 (en) 1995-06-30
JPS63246320A (ja) 1988-10-13
EP0280394A1 (fr) 1988-08-31
EP0280394B1 (fr) 1994-12-14
KR880008802A (ko) 1988-09-13
DE3852409T2 (de) 1995-04-20
DK32388A (da) 1988-07-28
ATE115403T1 (de) 1994-12-15
IE880179L (en) 1988-07-27
US4963363A (en) 1990-10-16
JP2677576B2 (ja) 1997-11-17
AU604288B2 (en) 1990-12-13
CA1314213C (fr) 1993-03-09
ES2068197T3 (es) 1995-04-16
NO880272L (no) 1988-07-27
IE65987B1 (en) 1995-11-29
NO177774B (no) 1995-08-14

Similar Documents

Publication Publication Date Title
NO177774C (no) Fremgangsmåte for fremstilling av et preparat egnet for tilförsel av en hovedsakelig vannuopplöslig aktiv bestanddel
HUT50794A (en) Herbicides comprising substituted benztriazole derivatives as active ingredient and process for producing the active ingredients
CA2281473A1 (fr) Forme galenique presentant des proprietes de dispersion rapide, ses procedes d'utilisation et son procede de preparation
IE940583L (en) Topical antimicrobial pharmaceutical compositions
HUT41221A (en) Insecticide and acaricide compositions further process for preparing phenoxy-alkyl-amino-pyridine derivatives as active ingredients thereof
HUT45850A (en) Insecticides comprising azolinone derivatives as active ingredient and process for producing the active ingredients
HUT50624A (en) Process for producing pharmaceuical compositions with controlled release of active ingredient
HUT53634A (en) Herbicides comprising aromatic carboxylic acid derivatives as active ingredient and process for producing the active ingredients
HUT47383A (en) Fungicides and insecticides comprising 2-anilino-pyrimidine derivatives as active ingredient and process for producing the active ingredients
NO962972L (no) Preparat for perkutan absorpsjon
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
HUT47392A (en) Insecticides comprising condensed heterocyclic compounds substituted with nitro group as active ingredient and process for producing the active ingredients
CA2117769A1 (fr) Composition de liposome
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
HUT49875A (en) Herbicides comprising substituted sulfonylaminoazole derivatives as active ingredient and process for producing the active ingredients
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
HUT49596A (en) Herbicides comprising iminophenylthiazolidine derivatives as actie ingredient and process for producing the active ingredients
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
SE8600496L (sv) Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider
FI896086A0 (fi) Menetelmä 2,4-di-t-butyylifenolin fosforiorgaanisten johdannaisten, bifenyylin 4,4'-dihalogeenimagnesium-yhdisteiden valmistamiseksi ja fosforiorgaanisten johdannaisten käyttö tekoaineiden, erityisesti polyolefiini-muovausmassojen stabilointiin
HUT47397A (en) Herbicides comprising sulfonyl-amino-guanidino-azine derivatives as active ingredient and process for producing the active ingredients
HUT45995A (en) Pesticides comprising acyloxy-thiophene-urea derivatives as active ingredient and process for producing the active ingredients
HUT48606A (en) Fungicides comprising hydroxyalkyltriazolyl derivatives as active ingredient and process for producing the active ingredients
HUT48223A (en) Herbicide comprising oxadiazolone derivatives as active ingredient and process for producing the active ingredient
HUT47540A (en) Herbicides comprising 1-phenyl-5-exomethylene-pyrrolidin-2-one derivatives as active ingredient and process for producing the active ingredients